Navigation Links
Mammograms Reduce Breast Cancer Deaths, But Increase Overdiagnosis

A new review of studies offers good news and bad news for women faced with the decision about whether to get regular mammograms.//

The good news is that screening mammography does reduce breast cancer mortality. The review found that women offered screening mammograms are 15 percent less likely to die of breast cancer than women who are not offered mammograms.

The bad news is that women in a screened population are 30 percent more likely to be diagnosed and treated for a cancer that, in the absence of screening, would never have posed a threat to their health.

“It is likely that screening mammography reduces breast cancer mortality, but the other side of the coin is the major harm of overdiagnosis and overtreatment,” said lead author Peter G?tzsche, M.D., director of the Nordic Cochrane Centre in Copenhagen, Denmark.

The review appears in the current issue of The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates research in all aspects of health care. Systematic reviews draw evidence-based conclusions about medical practice after considering both the content and quality of existing trials on a topic.

Mammograms can detect tumors that are too small to be felt as a lump, theoretically identifying cancer at its earliest and most treatable stage. In the United States, women are recommended to have regular mammograms beginning at age 40. While most European countries also recommend screening mammography, their guidelines advise that women begin screening at age 50.

To determine whether offering mammograms to women with no history or symptoms of breast cancer actually reduces breast cancer mortality, the reviewers pooled together findings from six randomized controlled trials involving half a million women. The researchers excluded a seventh trial from analysis because it was considered too biased to provide reliable data.

Most of
'"/>




Page: 1 2 3 4

Related medicine news :

1. Mammograms Reduce Risk of Dying
2. Mammograms better than self-exam
3. Accuracy of Mammograms
4. Frequent Mammograms Can Decreases The Risk of Death
5. Mammograms The Best In Detecting Breast Cancer
6. Mammograms Detect Non Progressive Cancer
7. Older Women Have Fewer Mammograms Than is Reported
8. Studies Report Mammograms Unsafe
9. Mammograms in Queensland Reviewed
10. Women Do Not Have Access To Free Mammograms
11. Use of Mammograms in Men

Post Your Comments:
(Date:12/2/2009)...tailing plastic surgery procedures is now availabl...dates can view procedures and print out informatio... (PRWEB) December 2, 2009 -- Recovery..., has always been dedicated to providing resources...es, providing liposuction garments, breast augment...
(Date:12/2/2009)...chieves IBM Ready for LINUX designation and enhanc...mainframe and contemporary systems running Linux. ...ember 2, 2009 -- eCube Systems, a leader in legacy...nounced that it has achieved the IBM Ready for LIN...dleware. This mark certifies NXTera has met compa...
(Date:12/2/2009)...-- A randomized, controlled study comparing standa...eatment called percutaneous disc decompression for...reatments help patients in the short run, only dis...years later. Results of the study, the first of it... of the Radiological Society of North America (RSN...
(Date:12/2/2009)... comparing standard conservative therapy to a mini...decompression for painful herniated disc revealed ...ort run, only disc decompression kept patients pai..., the first of its kind, were presented today at t...orth America (RSNA). , Discs are sponge-like cus...
(Date:12/1/2009)...swire/ -- Reportlinker.com announces that a new ma...: ,, The Future of Central Nervous System Dise...etitive Benchmarking, Product Pipeline and Deals A...14/The-Future-of-Central-Nervous-System-Diseases-T...-Benchmarking-Product-Pipeline-and-Deals-Analysis....
Breaking Medicine News(10 mins):Health News:Online Compression Garments Retailer Introduces 3D Animation of Surgical Procedures 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 2Health News:eCube Delivers Linux on System z Support for NXTera High Performance Middleware 3Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 2Health News:Outpatient Disc Treatment Gives Long-Term Back Pain Relief 3Health News:Outpatient disc treatment gives long-term back pain relief 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Central Nervous System Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22
... Johnson &,Johnson will participate in the Eleven...ence on Tuesday, March 18th at the Loews Miami Bea...resident, Finance and Chief,Financial Officer, wil...,by accessing the Johnson & Johnson website at ht...
... Liu, CEO and Founder of,Ingenious Med and a pract...ntly appointed to serve on the Benchmarks Committe...Liu and the rest of the Benchmarks Committee,will ...arks for hospitalists nationwide in the areas of h...
...athon(R) is pleased to,announce a new Small Child ...der volume instrument with patent-pending NeuralHa...ealth care providers to measure,bladder volume non...ced BladderScan(R) BVI 9400 will make its official...
...rsity of Maryland study of whether people receive ...r race or ethnicity found that when whites and min...ason, they receive the same quality care in that h...ch 11 issue of Health Affairs. The study of 1841 h...
...ral candidate at Georgetown University, has been n...nor Society (Bouchet Society). Crawford is in the...ve Cancer Center, part of the Georgetown Universit...76). The Society aims to recognize outstanding sc...
...or Disease Control has awarded the Indiana Univers...ract with the possibility of nearly $10 million in...ability of local, state and regional entities to s... emergencies. , The funding will allow researcher...
Other Medicine News:Health News:Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Committee at SHM 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 3Health News:Minorities, whites get equal care in hospitals 2Health News:Georgetown U student selected for prestigious Bouchet Society 2Health News:Regenstrief Institute tapped by CDC to combat potentially catastrophic disease outbreaks 2
(Date:12/1/2009)... Wash., Dec. 1 SCOLR Pha...ember 20, 2009 it licensed to Chrono Nutraceutical...d sell four extended release dietary supplements u...latform. In addition, SCOLR granted Chrono rights...he United States on a nonexclusive basis. Chrono ...
(Date:12/1/2009)..., Dec. 1 CEL-SCI Corpora...pany and a developer of vaccines and therapeutics ...eases, announced today that it has retained the se...ization (CRO) to run CEL-SCI,s upcoming Phase III ...ancer with the Company,s lead product candidate, M...
(Date:12/1/2009)...LLE, N.C., Dec. 1 nContact Surgica...n of devices for minimally-invasive treatment for ...f a feasibility clinical trial designed to evaluat...nd catheter procedure, the convergent procedure, f...fibrillation (AF). This prospective, feasibility ...
Breaking Medicine Technology:SCOLR Pharma, Inc. Licenses Dietary Supplements 2SCOLR Pharma, Inc. Licenses Dietary Supplements 3CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 2CEL-SCI Retains Global Contract Research Organization to Manage Upcoming Phase III Clinical Trial for Its Cancer Drug Multikine 3nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 1Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 2Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 3Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 4Eli Lilly and Company Opens Eco Friendly Biotechnology Center on the West Coast Designed to Speed and Enhance Innovation 5848 5Patent Attorneys McDaniel and Stipkala to Confer at Summit November 4 2009 60349 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 1House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 2House Healthcare Bill 3A Government Run Plan Other Key Provisions Undermine Goals of Access and Affordability 60346 3
...ggest Clinically Meaningful Primary Endpoint for C...tional World Muscle Society,Congress -, SOUTH PLA...TC) today announced promising findings in patients... at the 13th International World Muscle Society,(W...assessing the utility,of the 6-minute walk test (6...
...ent inhibitor to be tested in AMD patients, LOUIS...privately held biotechnology company developing me...egeneration (AMD) announced today that the,Company...positive safety,results in its Phase I study. POT-...complement activation cascade that could otherwise...
Other Medicine Technology:PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 2PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 3PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 4PTC Therapeutics Announces Data Showing Six-Minute Walk Test Consistently Measures Ambulatory Function in Patients With Duchenne Muscular Dystrophy 5Potentia Pharmaceuticals Announces Positive Safety Data and Study Expansion in Phase I Trial for Lead Drug Candidate POT-4 2
...c has been a key participant in the area of blood ...us Medtronic autotransfusion systems allowed clini...latelets, as well as to determine requirements for...ch plasma (PRP) for a small amount of autologous b...
RX HERCULINK® PLUS Biliary Stent System
Response Catheter
Fast-Cath™ Guiding Introducers
Medicine Products: